Provan D - Search Results

1

Updated international consensus report on the investigation and management of primary immune thrombocytopenia.

Provan D, Arnold DM, Bussel JB, Chong BH, Cooper N, Gernsheimer T, Ghanima W, Godeau B, González-López TJ, Grainger J, Hou M, Kruse C, McDonald V, Michel M, Newland AC, Pavord S, Rodeghiero F, Scully M, Tomiyama Y, Wong RS, Zaja F, Kuter DJ. Provan D, et al. Blood Adv. 2019 Nov 26;3(22):3780-3817. doi: 10.1182/bloodadvances.2019000812. Blood Adv. 2019. PMID: 31770441 Free PMC article.

2

Major histocompatibility complex susceptibility genes and immune thrombocytopenic purpura in Caucasian adults.

Stanworth SJ, Turner DM, Brown J, McCloskey D, Brown C, Provan D, Navarrete CV, Newland AC. Stanworth SJ, et al. Among authors: provan d. Hematology. 2002 Apr;7(2):119-21. doi: 10.1080/10245330290028605. Hematology. 2002. PMID: 12186703

3

Fifty years of idiopathic thrombocytopenic purpura (ITP): management of refractory itp in adults.

Provan D, Newland A. Provan D, et al. Br J Haematol. 2002 Sep;118(4):933-44. doi: 10.1046/j.1365-2141.2002.03669.x. Br J Haematol. 2002. PMID: 12199770 Free article. Review. No abstract available.

4

In vitro cytotoxic effects of stabilizing sugars within human intravenous immunoglobulin preparations against the human macrophage THP-1 cell-line.

Williams MA, Rhoades CJ, Provan D, Newland AC. Williams MA, et al. Among authors: provan d. Hematology. 2003 Oct;8(5):285-94. doi: 10.1080/10245330310001604746. Hematology. 2003. PMID: 14530170

5

Adult idiopathic thrombocytopenic purpura.

Mead AJ, Newland AC, Provan D. Mead AJ, et al. Among authors: provan d. Hematology. 2003 Dec;8(6):345-57. doi: 10.1080/1024533032000158850. Hematology. 2003. PMID: 14668028 Review. No abstract available.

6

Idiopathic thrombocytopenic purpura in adults.

Provan D, Newland A. Provan D, et al. J Pediatr Hematol Oncol. 2003 Dec;25 Suppl 1:S34-8. doi: 10.1097/00043426-200312001-00008. J Pediatr Hematol Oncol. 2003. PMID: 14668637 Review.

7

Alpha-galactosylceramide-driven expansion of human natural killer T cells is inhibited by prednisolone treatment.

Johansson U, Macey MG, Kenny D, Provan D, Newland AC. Johansson U, et al. Among authors: provan d. Br J Haematol. 2004 May;125(3):400-4. doi: 10.1111/j.1365-2141.2004.04896.x. Br J Haematol. 2004. PMID: 15086423 Free article.

8

Comparison of rHuEpo plus rHuG-CSF and supportive care: apples to oranges.

Stasi R, Amadori S, Newland AC, Provan D. Stasi R, et al. Among authors: provan d. Blood. 2004 Oct 1;104(7):2201; author reply 2201-2. doi: 10.1182/blood-2004-04-1334. Blood. 2004. PMID: 15377575 Free article. No abstract available.

9

Helicobacter pylori eradication in the management of patients with idiopathic thrombocytopenic purpura.

Stasi R, Rossi Z, Stipa E, Amadori S, Newland AC, Provan D. Stasi R, et al. Among authors: provan d. Am J Med. 2005 Apr;118(4):414-9. doi: 10.1016/j.amjmed.2004.09.014. Am J Med. 2005. PMID: 15808140

10

Management of cancer-related anemia with erythropoietic agents: doubts, certainties, and concerns.

Stasi R, Amadori S, Littlewood TJ, Terzoli E, Newland AC, Provan D. Stasi R, et al. Among authors: provan d. Oncologist. 2005 Aug;10(7):539-54. doi: 10.1634/theoncologist.10-7-539. Oncologist. 2005. PMID: 16079321 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page